Evidence map›Paper›PMID 42865417›Full record

ArticleFrontiers in oncology2026

M2 macrophage-derived exosomes and miR-132-3p promote gastric cancer cell aggressiveness and attenuate ferroptosis-related changes.

Tao Zhang, Yong Huang, Peng Cheng, Songhan Qin, Yifan Cao, Ming Xie, Jiwei Wang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tao Zhang *Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yong Huang *Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Peng ChengDepartment of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Songhan QinDepartment of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yifan CaoDepartment of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ming XieDepartment of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jiwei WangDepartment of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to explore the correlation between the ability of M2-type tumor-correlated macrophage-derived exosomes (EXOs) to trigger the aggressiveness of gastric cancer (GC) cells and the miR-132-3p expression. Methods: EXOs were isolated from the conditioned media of M0 and M2 macrophages and characterized by transmission electron microscopy and Western blotting. miR-132-3p expression was determined by qRT-PCR. HGC-27 cells were divided into the control, miR-132-3p mimic, miR-132-3p inhibitor, M0-EXO, and M2-EXO groups. Cell viability, proliferation, migration, and invasion were assessed using CCK-8, EdU, and Transwell assays. Intracellular GSH, SOD, MDA, and iron levels were measured using colorimetric assays. FTH1, LIFR, and GPX4 expressions were detected by Western blotting. RNA sequencing and bioinformatics analyses were performed to investigate miR-132-3p-mediated transcriptional changes and ferroptosis-related pathways in HGC-27 cells. Results: miR-132-3p was significantly enriched in M2 macrophage-derived exosomes and was highly expressed in GC, with its expression associated with tumor stage, grade, and other clinicopathological features. M2-Exo treatment significantly increased miR-132-3p levels in HGC-27 cells. Both miR-132-3p overexpression and M2-Exo treatment enhanced the proliferation, migration, and invasion of HGC-27 cells, and were accompanied by reduced intracellular iron and MDA levels, increased GSH content and SOD activity, upregulated FTH1 and GPX4 expression, and decreased LIFR expression. In contrast, miR-132-3p inhibition produced largely opposite effects. RNA-seq identified 275 differentially expressed genes following miR-132-3p overexpression, including 216 upregulated and 59 downregulated genes. GO and KEGG analyses revealed significant alterations in biological processes and pathways related to oxygen transport, ATP synthesis, oxidative phosphorylation, thermogenesis, spliceosome function, and endoplasmic reticulum protein processing. Integration of the RNA-seq-derived DEGs with FerrDb identified 12 ferroptosis-related DEGs, including 11 upregulated genes and 1 downregulated gene. qRT-PCR validation showed expression patterns broadly consistent with the RNA-seq results. Conclusion: miR-132-3p expression in the EXOs of M2-type macrophages was significantly elevated, and the EXOs of M2-type macrophages significantly triggered the aggressiveness of GC cells and inhibited ferroptosis in GC cells, which may be resulting from the prevention of ferroptosis through the transport of miR-132-3p; nevertheless, the specific mechanism of action needs to be further elucidated.

Indexed as

exosomeferroptosisgastric cancerMiR-132-3ptumor microenvironment

Identifiers

PMID42865417
PMCPMC13654736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.